Insider Trading Alert - QEP, PKG And RMD Traded By Insiders

Editor's Note: Any reference to TheStreet Ratings and its underlying recommendation does not reflect the opinion of TheStreet, Inc. or any of its contributors including Jim Cramer or Stephanie Link.

Yesterday, March 4, 2014, 177 U.S. common stocks issued filings of shares being bought or sold by insiders. The transactions ranged in value from $2,320.24 to $419,318,750.00.

Highlighted Stocks Traded by Insiders:

QEP Resources (QEP) - FREE Research Report

Heinemann Robert who is Director at QEP Resources bought 7,200 shares at $28.70 on March 4, 2014. Following this transaction, the Director owned 7,200 shares meaning that the stake was reduced by 100% with the 7,200-share transaction.

OConnor Thomas C who is Director at QEP Resources bought 5,000 shares at $28.91 on March 4, 2014. Following this transaction, the Director owned 11,302 shares meaning that the stake was reduced by 79.34% with the 5,000-share transaction.

Dill Julie who is Director at QEP Resources bought 250 shares at $28.37 on March 4, 2014. Following this transaction, the Director owned 525 shares meaning that the stake was reduced by 90.91% with the 250-share transaction.

The shares most recently traded at $29.08, up $0.71, or 2.44% since the insider transaction. Historical insider transactions for QEP Resources go as follows:

  • 4-Week # shares sold: 3,300
  • 12-Week # shares sold: 3,300
  • 24-Week # shares sold: 3,300

The average volume for QEP Resources has been 2.7 million shares per day over the past 30 days. QEP Resources has a market cap of $5.1 billion and is part of the basic materials sector and energy industry. Shares are down 7.24% year-to-date as of the close of trading on Tuesday.

QEP Resources, Inc., through its subsidiaries, operates as an independent oil and natural gas exploration and production company. The stock currently has a dividend yield of 0.28%. The company has a P/E ratio of 31.9. Currently there are 8 analysts that rate QEP Resources a buy, no analysts rate it a sell, and 4 rate it a hold.

Exclusive Offer: Get the latest Stock Analysis on QEP - FREE

TheStreet Quant Ratings rates QEP Resources as a hold. The company's strengths can be seen in multiple areas, such as its revenue growth, expanding profit margins and notable return on equity. However, as a counter to these strengths, we also find weaknesses including a generally disappointing performance in the stock itself, unimpressive growth in net income and generally higher debt management risk. Get the full QEP Resources Ratings Report from TheStreet Quant Ratings now.

STOCKS TO BUY: TheStreet Quant Ratings has identified a handful of stocks that can potentially TRIPLE in the next 12 months. Learn more.

Packaging Corporation of America (PKG) - FREE Research Report

Souleles Thomas S who is Director at Packaging Corporation of America bought 6,000 shares at $72.73 on March 4, 2014. Following this transaction, the Director owned 10,000 shares meaning that the stake was reduced by 150% with the 6,000-share transaction.

The shares most recently traded at $74.43, up $1.70, or 2.28% since the insider transaction. Historical insider transactions for Packaging Corporation of America go as follows:

  • 24-Week # shares sold: 128,907

The average volume for Packaging Corporation of America has been 951,700 shares per day over the past 30 days. Packaging Corporation of America has a market cap of $7.2 billion and is part of the consumer goods sector and consumer non-durables industry. Shares are up 15.14% year-to-date as of the close of trading on Tuesday.

Packaging Corporation of America engages in the manufacture and sale of containerboard and corrugated packaging products for industrial and consumer markets in the United States. The stock currently has a dividend yield of 2.2%. The company has a P/E ratio of 16.3. Currently there are 4 analysts that rate Packaging Corporation of America a buy, 1 analyst rates it a sell, and 5 rate it a hold.

Exclusive Offer: Get the latest Stock Analysis on PKG - FREE

TheStreet Quant Ratings rates Packaging Corporation of America as a buy. The company's strengths can be seen in multiple areas, such as its robust revenue growth, solid stock price performance, impressive record of earnings per share growth and compelling growth in net income. We feel these strengths outweigh the fact that the company shows low profit margins. Get the full Packaging Corporation of America Ratings Report from TheStreet Quant Ratings now.

STOCKS TO BUY: TheStreet Quant Ratings has identified a handful of stocks that can potentially TRIPLE in the next 12 months. Learn more.

ResMed (RMD) - FREE Research Report

Roberts Christopher G who is Director at ResMed sold 15,000 shares at $44.58 on March 4, 2014. Following this transaction, the Director owned 319,888 shares meaning that the stake was reduced by 4.48% with the 15,000-share transaction.

The shares most recently traded at $44.41, down $0.17, or 0.37% since the insider transaction. Historical insider transactions for ResMed go as follows:

  • 4-Week # shares sold: 19,287
  • 12-Week # shares sold: 44,287
  • 24-Week # shares sold: 120,850

The average volume for ResMed has been 1.3 million shares per day over the past 30 days. ResMed has a market cap of $6.2 billion and is part of the health care sector and health services industry. Shares are down 6.31% year-to-date as of the close of trading on Tuesday.

ResMed Inc., through its subsidiaries, engages in the development, manufacture, and distribution of medical equipment for treating, diagnosing, and managing sleep-disordered breathing and other respiratory disorders. The stock currently has a dividend yield of 2.3%. The company has a P/E ratio of 19.5. Currently there are 4 analysts that rate ResMed a buy, no analysts rate it a sell, and 7 rate it a hold.

Exclusive Offer: Get the latest Stock Analysis on RMD - FREE

TheStreet Quant Ratings rates ResMed as a buy. The company's strengths can be seen in multiple areas, such as its revenue growth, largely solid financial position with reasonable debt levels by most measures, notable return on equity, reasonable valuation levels and expanding profit margins. We feel these strengths outweigh the fact that the company shows weak operating cash flow. Get the full ResMed Ratings Report from TheStreet Quant Ratings now.

STOCKS TO BUY: TheStreet Quant Ratings has identified a handful of stocks that can potentially TRIPLE in the next 12 months. Learn more.

null

More from Markets

Apple and GE Switch Roles; Musk's Super Control of Tesla Explained -- ICYMI

Apple and GE Switch Roles; Musk's Super Control of Tesla Explained -- ICYMI

Trump May Be More to Blame For Higher Oil Prices Than OPEC

Trump May Be More to Blame For Higher Oil Prices Than OPEC

Dow Falls Over 200 Points as Apple's Slump Offsets Gains in General Electric

Dow Falls Over 200 Points as Apple's Slump Offsets Gains in General Electric

Week Ahead: Major Earnings on Tap as Wall Street Readies for Geopolitical Moves

Week Ahead: Major Earnings on Tap as Wall Street Readies for Geopolitical Moves

3 Hot Reads From TheStreet's Top Premium Columnists

3 Hot Reads From TheStreet's Top Premium Columnists